MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayly, R.
Right arrow Articles by LeBrun, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayly, R.
Right arrow Articles by LeBrun, D. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2006, p. 6442-6452, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.02025-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Critical Role for a Single Leucine Residue in Leukemia Induction by E2A-PBX1

Richard Bayly,1 Takayuki Murase,1 Brandy D. Hyndman,1 Rachel Savage,1 Salima Nurmohamed,1,2 Kim Munro,2 Richard Casselman,1 Steven P. Smith,2 and David P. LeBrun1*

Queen's University Cancer Research Institute, Department of Pathology and Molecular Medicine,1 Department of Biochemistry, Queen's University, Kingston, Ontario K7L 3N6, Canada2

Received 17 October 2005/ Returned for modification 16 December 2005/ Accepted 21 June 2006

In roughly 5% of cases of acute lymphoblastic leukemia, a chromosomal translocation leads to expression of the oncogenic protein E2A-PBX1. The N-terminal portion of E2A-PBX1, encoded by the E2A gene, is identical in sequence to the corresponding portion of the E proteins E12/E47 and includes transcriptional activation domains. The C terminus consists of most of the HOX interacting transcription factor PBX1, including its DNA-binding homeodomain. Structure-function correlative experiments have suggested that oncogenesis by E2A-PBX1 requires an activation domain, called AD1, at the extreme N terminus. We recently demonstrated that a potentially helical portion of AD1 interacts directly with the transcriptional coactivator protein cyclic AMP response element-binding protein (CBP) and that this interaction is essential in the immortalization of primary bone marrow cells in tissue culture. Here we show that a conserved LXXLL motif within AD1 is required in the interaction between E2A-PBX1 and the KIX domain of CBP. We show by circular dichroism spectroscopy that the LXXLL-containing portion of AD1 undergoes a helical transition upon interacting with the KIX domain and that amino acid substitutions that prevent helix formation prevent both the KIX interaction and cell immortalization by E2A-PBX1. Perhaps most strikingly, substitution of a single, conserved leucine residue (L20) within the LXXLL motif impairs leukemia induction in mice after transplantation with E2A-PBX1-expressing bone marrow. The KIX domain of CBP mediates well-characterized interactions with several transcription factors of relevance to leukemia induction. Circumstantial evidence suggests that the side chain of L20 might interact with a deep hydrophobic pocket in the KIX domain. Therefore, our results serve to identify a potential new drug target.


* Corresponding author. Mailing address: Division of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Kingston, Ontario K7L 3N6, Canada. Phone: (613) 533-3209. Fax: (613) 533-6830. E-mail: lebrun{at}cliff.path.queensu.ca.


Molecular and Cellular Biology, September 2006, p. 6442-6452, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.02025-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.